Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scholl is a global leader in foot care and podiatric health, offering a comprehensive range of products including orthotic insoles, specialized footwear, and over-the-counter medicinal treatments. Founded in 1906 by Dr. William Mathias Scholl, the company has established itself as a household name for addressing conditions such as fungal infections, warts, and biomechanical foot pain. The brand's portfolio includes advanced technologies like hydrogel-based cushioning and biomechanical mapping for custom-fit orthotics. Following its acquisition by Yellow Wood Partners, the brand's North American and international operations were consolidated into a single global entity. Scholl continues to innovate in the consumer healthcare space, focusing on skin health, comfort, and mobility for the lower limbs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scholl.